Sponsor pipeline

Centre Oscar Lambret clinical trial pipeline

Get alerts when Centre Oscar Lambret's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    SERCABOT · Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome

    Trial status changed: Recruiting → Withdrawn

    Also in this update: Primary completion date changed from estimate of Aug 30, 2027 to Sep 22, 2026; Start date changed from estimate of Oct 31, 2026 to Jun 10, 2025

    Centre Oscar LambretPhase 2 NCT06807164 Registry history of NCT06807164 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
3
Phase 3
2
Not charted: 16 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Centre Oscar Lambret's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free